US Patent Issued to Roche Diabetes Care on May 13 for "Method of determining a concentration of an analyte in a bodily fluid and mobile device configured for determining a concentration of an analyte in a bodily fluid" (German Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,730, issued on May 13, was assigned to Roche Diabetes Care Inc. (Indianapolis).

"Method of determining a concentration of an analyte in a bodily fluid and mobile device configured for determining a concentration of an analyte in a bodily fluid" was invented by Max Berg (Mannheim, Germany), Fredrik Hailer (Limburgerhof, Germany), Bernd Limburg (Soergenloch, Germany), Daria Skuridina (Berlin), Volker Tuerck (Berlin) and Momme Winkelnkemper (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of determining concentration of an analyte in a body fluid using a mobile device having a camera is disclosed. In the inventive method, the camera is u...